Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ:307750)
South Korea · Delayed Price · Currency is KRW 2,345.00
+45.00 (1.96%)
At close: Sep 18, 2026
Kookjeon Pharmaceutical Market Cap
Kookjeon Pharmaceutical has a market cap or net worth of 126.6 billion as of September 18, 2026. Its market cap has decreased by -37.29% in one year.
Market Cap
126.60B
Enterprise Value
135.34B
Revenue
134.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,345.00
ChartMarket Cap Chart
Since December 16, 2020, Kookjeon Pharmaceutical's market cap has increased from 37.63B to 126.60B, an increase of 236.47%. That is a compound annual growth rate of 23.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 126.60B | -25.02% |
| Dec 30, 2025 | 168.84B | -2.11% |
| Dec 30, 2024 | 172.48B | -43.67% |
| Dec 28, 2023 | 306.19B | -5.74% |
| Dec 29, 2022 | 324.84B | -39.54% |
| Dec 30, 2021 | 537.31B | 40.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| KCC Engineering & Construction | 127.97B |
| Seosan | 127.40B |
| Naintech CO.,LTD. | 127.17B |
| Unitrontech | 126.79B |
| DIO Corporation | 126.66B |
| Ghost Studio | 126.40B |
| Celemics | 126.35B |
| Y-Biologics | 126.31B |